Urine kryptopyrrole testing is one of the most debated—and least understood—assessments used in functional and integrative psychiatry. Often discussed anecdotally but rarely examined critically, this test has the potential to influence treatment decisions in patients with complex, treatment-resistant mental health symptoms.
In this webinar, Malcolm Sickels, MD, offers a clear, clinically grounded exploration of kryptopyrroles: what they are, how the test works, and what the current evidence does—and does not—support. We will examine the proposed biochemical mechanisms, review the limitations and gaps in the research, and discuss when kryptopyrrole testing may (or may not) be clinically useful.
Most importantly, this session will focus on practical application: how test results can inform thoughtful supplementation strategies, how to avoid over-interpretation, and how kryptopyrrole findings may fit into a broader functional psychiatry framework alongside labs, symptoms, and patient history.
This webinar is designed for clinicians who want to understand kryptopyrrole testing with nuance—bridging curiosity, skepticism, and real-world clinical decision-making.
